Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis

Thrombosis and Haemostasis

Volumn 89, Issue 3, 2003, Pages 561-572

  Aimes, Ronald T ^b   Zijlstra, Andries ^b   Hooper, John D ^b   Ogbourne, Steven M ^c   Sit, Mae Le ^c   Fuchs, Simone ^c   Gotley, David C ^d   Quigley, James P ^b   Antalis, Toni M ^a,b  

^a HOLLAND LABORATORY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Angiogenesis; Endothelial cell; Microvascular; Serine protease; Tubule morphogenesis

Indexed keywords

ACROSIN; DIPEPTIDYL PEPTIDASE IV; FIBRILLAR COLLAGEN; FIBRILLAR COLLAGEN TYPE 1; GENE PRODUCT; GLYCEROPHOSPHATE CALCIUM; HEPSIN; MATRIPTASE; MESSENGER RNA; NEUROTRYPSIN; OLIGONUCLEOTIDE; PLASMINOGEN; PROTEIN C; SEPRASE; SERINE PROTEINASE; TESTISIN; TRANSMEMBRANE PROTEASE SERINE TYPE 2; UNCLASSIFIED DRUG; UROKINASE;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULATURE; MOLECULAR CLONING; MORPHOGENESIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; UMBILICAL VEIN;

EID: 0037340473     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613388     Document Type: Article

References (78)

1. Risau W. Mechanisms of angiogenesis. Nature 1997; 386 (6626): 671-4.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1 (1): 7-31.
3. Carmeliet P, Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol 2000; 190 (3): 387-405.
4. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-95.
5. Rifkin DB, Mazzieri R, Munger JS, Noguera I, Sung J. Proteolytic control of growth factor availability. APMIS 1999; 107 (1): 80-5.
6. Plouet J, Moro F, Bertagnolli S, Coldebouef N, Mazarguil H, Clamens S et al. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J Biol Chem 1997; 272 (20): 13390-6.
7. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2(10):737-44.
8. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001; 21 (7): 1104-17.
9. Werb Z, Vu TH, Rinkenberger JL, Coussens LM. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 1999; 107 (1): 11-8.
10. Pepper MS, Montesano R, Mandriota SJ, Orci L, Vassalli J-D. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 1996; 49 (1-3): 138-62.
11. Van Hinsbergh VW, Koolwijk P, Hanemaaijer R. Role of fibrin and plasminogen activators in repair-associated angiogenesis: In vitro studies with human endothelial cells. EXS 1997; 79: 391-411.
12. Rawlings ND, Barrett AJ. Families of serine peptidases. Methods Enzymol 1994; 244: 19-61.
13. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al. Initial sequencing and analysis of the human genome. Nature 2001; 409 (6822): 860-921.
14. Krem MM, Rose T, Di Cera E. Sequence determinants of function and evolution in serine proteases. Trends Cardiovasc Med 2000; 10 (4): 171-6.
15. Neurath H. Proteolytic enzymes, past and present. Fed Proc 1985; 44 (14): 2907-13.
16. Degen JL, Drew AF, Palumbo JS, Kombrinck KW, Bezerra JA, Danton MJ et al. Genetic manipulation of fibrinogen and fibrinolysis in mice. Ann N Y Acad Sci 2001; 936: 276-90.
17. Clements J, Hooper J, Dong Y, Harvey T. The expanded human kallikrein (KLK) gene family: Genomic organisation, tissue-specific expression and potential functions. Biol Chem 2001; 382 (1): 5-14.
18. Kam CM, Hudig D, Powers JC. Granzymes (lymphocyte serine proteases): Characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 2000; 1477 (1-2): 307-23.
19. Hooper JD, Clements JA, Quigley JP, Antalis TM. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 2001; 276 (2): 857-60.
20. Kitamoto Y, Veile RA, Donis-Keller H, Sadler JE. cDNA sequence and chromosomal localization of human enterokinase, the proteolytic activator of trypsinogen. Biochemistry 1995; 34 (14): 4562-8.
21. Mann NS, Mann SK. Enterokinase. Proc Soc Exp Biol Med 1994; 206 (2): 114-8.
22. Kitamoto Y, Yuan X, Wu Q, McCourt DW, Sadler JE. Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains. Proc Natl Acad Sci USA 1994; 91 (16): 7588-92.
23. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1998; 107 (4): 1589-98.
24. Davis GE, Camarillo CW. An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 1996; 224 (1): 39-51.
25. Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 1999; 155 (3): 887-95.
26. Mookhtiar KA, Mallya SK, Van Wart HE. Properties of radiolabeled type I, II, and III collagens related to their use as substrates in collagenase assays. Anal Biochem 1986; 158 (2): 322-33.
27. Hooper JD, Nicol DL, Dickinson JL, Eyre HJ, Scarman AL, Normyle JF et al. Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors. Cancer Res 1999; 59 (13): 3199-205.
28. Tata AM. An in situ hybridization protocol to detect rare mRNA expressed in neural tissue using biotin-labelled oligonucleotide probes. Brain Res Brain Res Protoc 2001; 6 (3): 178-184.
29. Mintz GR. An irreversible serine protease inhibitor. Biopharmacology 1993; 6: 34-38.
30. Chu TM, Kawinski E. Plasmin, substilisin-like endoproteases, tissue plasminogen activator, and urokinase plasminogen activator are involved in activation of latent TGF-beta 1 in human seminal plasma. Biochem Biophys Res Commun 1998; 253 (1): 128-34.
31. Bestilny LJ, Riabowol KT. A role for serine proteases in mediating phorbol ester-induced differentiation of HL-60 cells. Exp Cell Res 2000; 256 (1): 264-71.
32. Citron M, Diehl TS, Capell A, Haass C, Teplow DB, Selkoe DJ. Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron 1996; 17 (1): 171-9.
33. Fussi F. Aprotinin: Mechanism of action and therapeutical uses. Boll Chim Farm 1980; 119 (11): 631-46.
34. Andreasen PA, Nielsen LS, Kristensen P, Grondahl-Hansen J, Skriver L, Dano K. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. J Biol Chem 1986; 261 (17): 7644-51.
35. Loskutoff DJ, Edgington TS. An inhibitor of plasminogen activator in rabbit endothelial cells. J Biol Chem 1981; 256 (9): 4142-5.
36. Takeuchi T, Shuman MA, Craik CS. Reverse biochemistry: Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA 1999; 96 (20): 11054-61.
37. Bykowska K, Levin EG, Rijken DC, Lostukoff DJ, Collen D. Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells. Biochim Biophys Acta 1982; 703 (1): 113-5.
38. Proba K, Gschwend TP, Sonderegger P. Cloning and sequencing of the cDNA encoding human neurotrypsin. Biochim Biophys Acta 1998; 1396 (2): 143-7.
39. Baba T, Watanabe K, Kashiwabara S, Arai Y. Primary structure of human proacrosin deduced from its cDNA sequence. FEBS Lett 1989; 244 (2): 296-300.
40. Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T et al. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta 1997; 1350 (1): 11-4.
41. Reseland JE, Larsen F, Solheim J, Eriksen JA, Hanssen LE, Prydz H. A novel human chymotrypsin-like digestive enzyme. J Biol Chem 1997; 272 (12): 8099-104.
42. Foster D, Davie EW. Characterization of a cDNA coding for human protein C. Proc Natl Acad Sci USA 1984; 81 (15): 4766-70
43. Lin CY, Anders J, Johnson M, Dickson RB. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 1999; 274 (26): 18237-42.
44. Paoloni-Giacobinoo A, Chen H, Peitsch MC, Rossier C, Antonarakis SE. Cloning of the TMPRSS2 gene, while encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 1997; 44(3): 309-20.
45. Leytus SP, Loeb KR, Hagen FS, Kurachi K, Davie EW. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry 1988; 27 (3): 1067-74.
46. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Troto P et al. Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J Biol Chem 1992; 267 (7):4824-33.
47. Goldstein LA, Ghersi G, Pineiron-Sanchez ML, Salamone M, Yeh Y, Flessate D et al. Molecular cloning of seprase: A serine integral membrane protease from human melanoma. Biochim Biophys Acta 1997; 1361 (1): 11-9.
48. Campanelli D, Melchoir M, Fu Y, Nakata M, Shuman H, Nathan C et al. Cloning of cDNA for proteinase 3: A serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 1990; 172(6): 1709-15.
49. Yan W, Sheng N, Seto M, Morser J, Wu Q. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 1999; 274(21): 14926-35.
50. Yamaoka K, Masuda K, Ogawa H, Takagi K, Umemoto N, Yasuoka S. Cloning and characterization of the cDNA for human airway trypsin-like protease. J Biol Chem 1998; 273 (19): 11895-901.
51. Kim DR, Sharmin S, Inoue M, Kido H. Cloning and expression of novel mosaic serin proteases with and without a transmembrane domain from human lung. Biochim Biophys Acta 2001; 1518 (1-2): 204-9.
52. Yu JX, Chao L, Chao J. Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA. J Biol Chem 1995; 270 (22): 13483-9.
53. Scott HS, Kudoh J, Wattenhofer M. Shibuya K, Berry A, Chrast R et al. Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet 2001; 27 (1): 59-63.
54. Wallrapp C, Hahnel S, Muller-Pillasch F, Burghardt B, Iwamura T, Ruthenburger M et al. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res 2000; 60 (10): 2602-6.
55. Davis GE, Pintar Allen KA, Salzar R, Maxwell SA. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 2001; 114 (Pt 5): 917-930
56. Bahou WF, Potter CL, Mirza H.z The VLA-2 (alpha 2 beta 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: Molecular and functional characterization. Blood 1994; 84 (11): 3734-41.
57. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 1997; 94 (25): 13612-7.
58. Grant DS, Tashiro K, Segui-Real B. Yamada Y, Martin GR,Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989; 58 (5): 933-43.
59. Seandel M, Noack-Kunnmann K, Zhu D, Aimes RT, Quigley JP. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood 2001; 97 (8): 2323-32.
60. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: Regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 2001; 114 (Pt 15): 2755-73.
61. Kahn J, Mehraban F, Ingle G, Xin X, Bryant JE, Vehar G et al. Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol 2000; 156 (6): 1887-900.
62. Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Engn K et al. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: A potential method for objective assessment of tumor angiogenesis. Int J Cancer 2000; 85 (2): 281-8.
63. Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S et al. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001; 188 (1): 1-7.
64. Ortega N, Hutchings H, Plouet J. Signal relays in the VEGF system. Front Biosci 1999; 4: D141-D152.
65. Kashiwabara S, Baba T, Takada M, Watanabe K, Yano Y, Arai Y. Primary structure of mouse proacrosin deduced from the cDNA sequence and its gene expression during spermatogenesis. J Biochem (Tokyo) 1990; 108 (5): 785-791.
66. Inoue M, Kanbe N, Kurosawa M, Kido H. Cloning and tissue distribution of a novel serine protease esp-1 from human eosinophils. Biochem Biophys Res Commun 1998; 252 (2): 307-12.
67. Tsuji A, Torres-Rosado A, Arai T, Le Beau MM, Lemons RS, Chou SH et al. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem 1991; 266 (25): 16948-53.
68. Gschwend TP, Krueger SR, Kozlov SV, Wolfer DP, Sonderegger P. Neurotrypsin, a novel multidomain serine protease expressed in the nervous system. Mol Cell Neuorosci 1997; 9 (3): 207-19.
69. Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics 1999; 62 (2): 251-9.
70. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P. Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma. Clin Biochem 2000; 33 (7): 579-83.
71. Esmon CT. The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway. J Autoimmun 2000; 15 (2): 113-6.
72. Kazama Y, Hamamoto T, Foster DC, Kisiel W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 1995; 270 (1): 66-72.
73. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999; 274 (19): 13066-13076.
74. Lee SL, Dickson RB, Lin CY. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 2000; 275(47):36720-5.
75. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 2000; 275 (34): 26333-42.
76. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 1994; 54 (21); 5702-10.
77. Gonzalez-Gronow M, Grenett HE, Weber MR, Gawdi G, Pizzo SV. Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. Biochem J 2001; 355 (Pt 2): 397-407.
78. Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC et al. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res 2001; 61 (4): 1686-92.